The NLRP3 inflammasome activation enhanced the proliferation and suppressed the apoptosis of lymphoma cells through upregulation of c-myc and B-cell lymphoma-2 (Bcl-2), and downregulation of tumor protein p53 (TP53) and Bcl-2-associated X protein (Bax) [69]. This evidence concerns the gene TP53 and lymphoma.